Clinical Features in Patients With Malignant Pleural Mesothelioma With 5-Year Survival and Evaluation of Original Diagnoses

Juuso Paajanen; Sanna Laaksonen; Ilkka Ilonen; Tapio Vehmas; Mikko I. Mäyränpää; Eva Sutinen; Eeva Kettunen; Jarmo A. Salo; Jari Räsänen; Henrik Wolff; Marjukka Myllärniemi

doi:10.1016/j.cllc.2020.05.020

Clinical Features in Patients With Malignant Pleural Mesothelioma With 5-Year Survival and Evaluation of Original Diagnoses

Juuso Paajanen, Sanna Laaksonen, Ilkka Ilonen, Tapio Vehmas, Mikko I. Mäyränpää, Eva Sutinen, Eeva Kettunen, Jarmo A. Salo, Jari Räsänen, Henrik Wolff, Marjukka Myllärniemi

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Journal	Clinical Lung Cancer
Volume	21
Issue number	6
Pages (from-to)	E633-E639
Number of pages	7
ISSN	1525-7304
DOIs	https://doi.org/10.1016/j.cllc.2020.05.020
Publication status	Published - Nov 2020
MoE publication type	A1 Journal article-refereed

Fields of Science

Clinical factors
Diagnostic assessment
Long-term survivors
Prognostic factors
Survival time
LONG-TERM SURVIVAL
PROGNOSTIC-FACTORS
BIOMARKERS
HISTORY
SURGERY
FUTURE
SCORE
3122 Cancers
3121 General medicine, internal medicine and other clinical medicine
3126 Surgery, anesthesiology, intensive care, radiology

Access to Document

10.1016/j.cllc.2020.05.020

CLC Clean Copy Paajanen-Laaksonen 260420Accepted author manuscript, 730 KBLicence: CC BY-NC-ND

Cite this

Paajanen, J., Laaksonen, S., Ilonen, I., Vehmas, T., Mäyränpää, M. I., Sutinen, E., Kettunen, E., Salo, J. A., Räsänen, J., Wolff, H., & Myllärniemi, M. (2020). Clinical Features in Patients With Malignant Pleural Mesothelioma With 5-Year Survival and Evaluation of Original Diagnoses. Clinical Lung Cancer, 21(6), E633-E639. https://doi.org/10.1016/j.cllc.2020.05.020

@article{e95060d91b634b4f84dd9dcacc925ad2,

title = "Clinical Features in Patients With Malignant Pleural Mesothelioma With 5-Year Survival and Evaluation of Original Diagnoses",

keywords = "Clinical factors, Diagnostic assessment, Long-term survivors, Prognostic factors, Survival time, LONG-TERM SURVIVAL, PROGNOSTIC-FACTORS, BIOMARKERS, HISTORY, SURGERY, FUTURE, SCORE, 3122 Cancers, 3121 General medicine, internal medicine and other clinical medicine, 3126 Surgery, anesthesiology, intensive care, radiology",

author = "Juuso Paajanen and Sanna Laaksonen and Ilkka Ilonen and Tapio Vehmas and M{\"a}yr{\"a}np{\"a}{\"a}, {Mikko I.} and Eva Sutinen and Eeva Kettunen and Salo, {Jarmo A.} and Jari R{\"a}s{\"a}nen and Henrik Wolff and Marjukka Myll{\"a}rniemi",

year = "2020",

month = nov,

doi = "10.1016/j.cllc.2020.05.020",

language = "English",

volume = "21",

pages = "E633--E639",

journal = "Clinical Lung Cancer",

issn = "1525-7304",

publisher = "CIG MEDIA GROUP, LP",

number = "6",

}

Paajanen, J, Laaksonen, S, Ilonen, I, Vehmas, T, Mäyränpää, MI , Sutinen, E, Kettunen, E, Salo, JA , Räsänen, J, Wolff, H & Myllärniemi, M 2020, 'Clinical Features in Patients With Malignant Pleural Mesothelioma With 5-Year Survival and Evaluation of Original Diagnoses', Clinical Lung Cancer, vol. 21, no. 6, pp. E633-E639. https://doi.org/10.1016/j.cllc.2020.05.020

TY - JOUR

T1 - Clinical Features in Patients With Malignant Pleural Mesothelioma With 5-Year Survival and Evaluation of Original Diagnoses

AU - Paajanen, Juuso

AU - Laaksonen, Sanna

AU - Ilonen, Ilkka

AU - Vehmas, Tapio

AU - Mäyränpää, Mikko I.

AU - Sutinen, Eva

AU - Kettunen, Eeva

AU - Salo, Jarmo A.

AU - Räsänen, Jari

AU - Wolff, Henrik

AU - Myllärniemi, Marjukka

PY - 2020/11

Y1 - 2020/11

KW - Clinical factors

KW - Diagnostic assessment

KW - Long-term survivors

KW - Prognostic factors

KW - Survival time

KW - LONG-TERM SURVIVAL

KW - PROGNOSTIC-FACTORS

KW - BIOMARKERS

KW - HISTORY

KW - SURGERY

KW - FUTURE

KW - SCORE

KW - 3122 Cancers

KW - 3121 General medicine, internal medicine and other clinical medicine

KW - 3126 Surgery, anesthesiology, intensive care, radiology

U2 - 10.1016/j.cllc.2020.05.020

DO - 10.1016/j.cllc.2020.05.020

M3 - Article

SN - 1525-7304

VL - 21

SP - E633-E639

JO - Clinical Lung Cancer

JF - Clinical Lung Cancer

IS - 6

ER -